Physician profile
David F Sutter
NPI 1659351500
$706.29
in general payments reported to CMS, 2019-2025
14 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.74 · 2020: $46.05 · 2021: $41.83 · 2022: $11.71 · 2023: $65.26 · 2024: $240 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $207.61 | 2019-2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $103.90 | 2024-2025 | Wegovy |
| Lilly USA, LLC | $57.32 | 2022-2024 | Jardiance, Zepbound, Mounjaro |
| Pfizer INC. | $56.86 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $55.96 | 2025 | |
| Dexcom, INC. | $40.74 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $36.24 | 2024 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $34.57 | 2024 | |
| Medtronic, INC. | $28.56 | 2025 | Symplicity G3 |
| Biosense Webster, INC. | $24.44 | 2025 | Nuvision Ice Catheter |
| Sanofi Pasteur INC. | $17.62 | 2025 | |
| Amgen INC. | $15.00 | 2023 | Otezla, Repatha |
| Sumitomo Pharma America, INC. | $14.61 | 2024 | Gemtesa |
| Redhill Biopharma INC. | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.